Physician profile
Wade W Kang
NPI 1164612453
$1,230.27
in general payments reported to CMS, 2019-2025
24 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $186 · 2022: $176 · 2023: $123 · 2024: $108 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $172.77 | 2019-2024 | Xarelto |
| Bard Peripheral Vascular, INC. | $126.65 | 2019-2025 | Lutonix Drug Coated Balloon |
| Smith+Nephew, INC. | $93.10 | 2019-2025 | Renasys Touch, Pico 7 |
| Medtronic Vascular, INC. | $89.06 | 2019-2020 | |
| Boston Scientific Corporation | $87.33 | 2022-2023 | Eluvia |
| Cook Medical LLC | $79.79 | 2019-2025 | Icast Covered Stent System, 6mmx22mmx120cm |
| Inari Medical, INC. | $68.23 | 2020 | |
| Kerecis Limited | $68.16 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Pfizer INC. | $56.32 | 2019-2024 | |
| Medtronic, INC. | $52.13 | 2023 | Venaseal |
| W. L. Gore & Associates, INC. | $46.80 | 2020-2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Cashflow Solutions, LLC | $39.83 | 2025 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Getinge USA Sales, LLC | $38.61 | 2019 | |
| Mozarc Medical US LLC | $33.30 | 2024 | Palindrome |
| Cardiovascular Systems INC. | $26.06 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avinger INC. | $23.70 | 2019 | |
| Covidien LP | $23.10 | 2019 | |
| Convatec INC. | $22.02 | 2024 | |
| Shionogi INC | $17.18 | 2019 | |
| Molnlycke Health Care US, LLC | $13.83 | 2019 | |
| Kci USA, INC. | $13.75 | 2022 | |
| Ekos Corporation | $13.46 | 2019 | |
| Medela LLC | $13.20 | 2019 | |
| Bolton Medical INC | $11.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wade Kang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.